참고문헌
- Agarwal G, Ramakant P, Forgach ER, et al (2009). Breast cancer care in developing countries. World J Surg, 33, 2069-2076. https://doi.org/10.1007/s00268-009-0150-z
- Akhsan A, Aryandono T, (2010). Prognostic factors of locally advanced breast cancer patients receiving neoadjuvant and adjuvant chemotherapy. Asian Pac J Cancer Prev, 11, 759-61.
- Bruin de MA, Kwong A, Goldstein BA, et al (2012). Breast cancer risk factors differ between Asian and white women with BRCA1 / 2 mutations. Fam Cancer, 11, 429-439. https://doi.org/10.1007/s10689-012-9531-9
- Brunham LR, Singaraja RR, Pape TD, et al (2005). Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet, 1, 739-747.
- Chen S, Parmigiani G (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol, 25, 1329-33. https://doi.org/10.1200/JCO.2006.09.1066
- Daly MB, Axilbund JE, Buys S, et al (2010). Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw, 8, 562-594. https://doi.org/10.6004/jnccn.2010.0043
- Gage M, Wattendorf D, Henry LR (2012). Translational advances regarding hereditary breast cancer syndromes. J Surg Oncol, 105, 444-451. https://doi.org/10.1002/jso.21856
- Hall MJ, Reid JE, Burbidge LA, et al (2009). BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer, 115, 2222-33. https://doi.org/10.1002/cncr.24200
- Han, Kim SW, Kang E, et al (2013). The prevalence of BRCA mutations among familial breast cancer patients in Korea: Results of the Korean Hereditary Breast Cancer study. Fam Cancer, 12, 75-81. https://doi.org/10.1007/s10689-012-9578-7
- Hartman AR, Kaldate RR, Sailer LM, et al (2012). Prevalence of BRCA mutations in an unselected population of triplenegative breast cancer. Cancer, 118, 2787-95. https://doi.org/10.1002/cncr.26576
- He M Di GH, Cao AY, et al (2012). RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer. Breast Cancer Res Treat, 133, 111-6. https://doi.org/10.1007/s10549-011-1700-2
- Janavicius R (2010). Founder BRCA1/2 mutations in the Europe: Implications for hereditary breast-ovarian cancer prevention and control. EPMA J, 1, 397-412. https://doi.org/10.1007/s13167-010-0037-y
- Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics: 2011. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kang E, Kim SW (2013). The korean hereditary breast cancer study: review and future perspectives. J Breast Cancer, 16, 245-53. https://doi.org/10.4048/jbc.2013.16.3.245
- Kang P, Mariapun S, Phuah SY, et al (2010). Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families. Breast Cancer Res Treat, 124, 579-84. https://doi.org/10.1007/s10549-010-1018-5
- Kim H, Choi DH (2013). Distribution of BRCA1 and BRCA2 mutations in asian patients with breast cancer. J Breast Cancer, 16, 357-365. https://doi.org/10.4048/jbc.2013.16.4.357
- Kim H, D'Andrea AD (2012). Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev, 26, 1393-408. https://doi.org/10.1101/gad.195248.112
- Kobayashi H, Ohno S, Sasaki Y, Matsuura M (2013). Hereditary breast and ovarian cancer susceptibility genes (Review). Oncol Rep, 30, 1019-29. https://doi.org/10.3892/or.2013.2541
- Leeneer de K, Coene I, Crombez B, et al (2012). Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: Implications for genetic testing. Breast Cancer Res Treat, 132, 87-95. https://doi.org/10.1007/s10549-011-1544-9
- Narod SA (2010). BRCA mutations in the management of breast cancer: The state of the art. Nat Rev Clin Oncol, 7, 702-7. https://doi.org/10.1038/nrclinonc.2010.166
- Purnomosari D, Pals G, Wahyono A, et al (2007). BRCA1 and BRCA2 germline mutation analysis in the Indonesian population. Breast Cancer Res Treat, 106, 297-304. https://doi.org/10.1007/s10549-006-9493-4
- Ripperger T, Gadzicki D, Meindl A, Schlegelberger B (2009). Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet, 17, 722-31. https://doi.org/10.1038/ejhg.2008.212
- Roy R, Chun J, Powell SN (2011). BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer, 12, 68-78. https://doi.org/10.1038/nrc3181
- Seong MW, Cho SI, Noh DY, et al (2009). Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population. Fam Cancer, 8, 505-8. https://doi.org/10.1007/s10689-009-9279-z
- Siegel R, Ma J. Zou Z, Jemal A (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
- The Breast Cancer Information Core Database (2012). Available at http://research. nhgri.nih.gov/projects/bic/
- Tavtigian SV, Deffenbaugh AM, Yin L, et al (2006). Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet, 43, 295-305.
- Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A (2008). Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Hum Mutat, 29, 1342-54. https://doi.org/10.1002/humu.20896
- Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011). Genetic variants associated with breast-cancer risk: Comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol, 12, 477-488. https://doi.org/10.1016/S1470-2045(11)70076-6